logo
  • About
    • AI in Hematology
    • The Platform
    • Our Manifesto
  • Pilots
    • Our use cases
    • Use cases metadata
  • Training
    • Training – Wave 1
    • Training – Wave 2
    • Educational Committee
  • Team
    • Partners
    • Advisory Board
  • Events
  • Publications
  • News
  • Show all
  • Articles
  • Clinical trials
  • Deliverables
  • Papers
  • Posters & Abstracts
  • Pre-prints
Clinical trials

March 15, 2021

GENOMED4ALL: Improving MDS Classification and Prognosis by AI

Papers

February 4, 2021

Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

Papers

February 1, 2021

Protein Stability Perturbation Contributes to the Loss of Function in Haploinsufficient Genes

Papers

November 5, 2020

A Sex-Informed Approach to Improve Prognostication and Personalized Decision-Making Process in Myelodysplastic Syndromes

  • 1
  • …
  • 11
  • 12
  • 13

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101017549.

© GenoMed4All. All rights reserved

Privacy Policy | Terms of Use